Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

TYRA Tyra Biosciences Inc

15,97

0,02 (0,13%)

08 Jan 2025 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

10/28/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Hiroomi Tada

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Tyra Biosciences (NASDAQ:TYRA)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse Tyra Biosciences

Tyra Biosciences (NASDAQ:TYRA)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse Tyra Biosciences

Actualités Tyra Biosciences Inc

Form 144 - Report of proposed sale of securities
Lundi 9 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Samedi 7 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 5 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mardi 3 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercredi 20 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Mercredi 20 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Tyra Biosciences to Present at Upcoming Investor Conferences
Mercredi 13 Novembre 2024 ( il y a 2 mois) • PR Newswire (US)

Form 8-K - Current report
Jeudi 7 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights
Jeudi 7 Novembre 2024 ( il y a 2 mois) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Mercredi 30 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lundi 28 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur Tyra Biosciences Inc

Lvmh Moet Hennessy Louis...

JP Morgan Chase

Societe Generale

Cie de SaintGobain

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales